The Association of Sexual Dysfunction and Substance Use Among a Community Epidemiological Sample

Abstract

This study examines the prevalence of DSM-III sexual dysfunctions and their association with comorbid drug and alcohol use in a community epidemiologic sample. The data for these analyses are based on the Epidemiological Catchment Area Project, a multistage probability study of the incidence and prevalence of psychiatric disorders in the general population conducted in 1981-83. Only the sample of 3,004 adult community residents in the St. Louis area was queried on DSM-III sexual dysfunctions of inhibited orgasm, functional dyspareunia (painful sex), inhibited sexual excitement (i.e., lack of erection/arousal), and inhibited sexual desire. There was a prevalence rate of 11% for inhibited orgasm, 13% for painful sex, 5% for inhibited sexual excitement, 7% for inhibited sexual desire, and 26% for any of these sexual dysfunctions (14% for men and 33% for women). The prevalence of qualifying lifetime substance use among the population was 37%, with males meeting more drug and alcohol use criteria than females. After controlling for demographics, health status variables, and psychiatric comorbidity (depression disorder, generalized anxiety disorder, antisocial personality disorder, and residual disorders), inhibited orgasm was associated with marijuana and alcohol use. Painful sex was associated with illicit drug use and marijuana use. Inhibited sexual excitement was more likely among illicit drug users. Inhibited sexual desire was not associated with drug or alcohol use.

Prevalence and correlates of sexual dysfunction among young adult married women in rural China: a population-based study

“…These gave some support to other studies reporting similar associations. 20,21 The current study further found that Chinese women with late menarche (13-14 vs p12 years) were at high risk of having SD (multivariate analysis), which is supported by another study. 22 Associations were found between SD and RTI, cervical erosion, menstrual disorders and use of IUD, which have not been well documented in the literature.…”

Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015

“…A somewhat higher prevalence of orgasmic dysfunction (30%) was reported from Finland. 2 In other studies, 16,18,19,26,27,32 the prevalence of orgasmic dysfunction was much lower (11%e16%), whereas that of mild orgasmic dysfunction was remarkably high (approximately 60%) in two Nordic countries, where identical methodology was used. Thus, in these two countries, more than 80% of all sexually active women 18 to 74 years old reported some degree of orgasmic dysfunction.…”

“…The prevalence of dyspareunia was reported as low as 1% in Australian women 34 and 2% in elderly British women, 35 whereas other studies found that dyspareunia was present in as many as 14% to 27% of women. 16,18,19,26,27,32 Several investigations described increasing dyspareunia with increasing age. 17,36 The Global Study of Sexual Attitudes and Behavior 20 reported pain during sexual intercourse to range from 5% in Northern Europe to 22% in Southeast Asia.…”

Análisis psicométrico de la versión española del Brief Sexual Function Inventory (BSFI) en una muestra de hombres con historia de abuso de drogas

“…Por un lado, se ha observado que, a dosis bajas y a corto plazo, el alcohol (Emanuele y Emanuele, 1998), las benzodiacepinas (Smith, 2007), el cannabis (Lévy y Garnier, 2006;McKay, 2005), la cocaí-na (Buffum, Moser y Smith, 1988;Peugh y Belenko, 2001;Rosen, 1991), los opioides (Hyatt y Bensky, 1999), las anfetaminas y las metanfetaminas (Degenhardt y Topp, 2003;Kurtz, 2005), y los alucinógenos (Lévy y Garnier, 2006) pueden llegar a mejorar diversas áreas del funcionamiento sexual, aunque habitualmente estos efectos son efímeros ya que se produce una rápida habituación. A dosis más elevadas y/o en periodos de tiempo más prolongados, los efectos de las drogas son devastadores, afectando tanto a los aspectos físiológicos del ciclo sexual (Argiolas, 1999;Crenshaw y Goldberg, 1996;Cocores, Miller, Pottash y Gold, 1988;Johnson, Phelps y Cottler, 2004), como a los aspectos psicológi-cos de la sexualidad (Aguilar et al, 2008;Ávila Escribano, Pérez Madruga, Ólazabal Ulacia y López Fidalgo, 2004;La Pera et al, 2003;Lévy y Garnier, 2006;Peugh y Belenko, 2001;Rosen, 1991;Smith, 2007). Asimismo, es importante destacar la influencia que el tabaco tiene sobre la respuesta sexual humana, tanto a corto, como a largo plazo (Gades et al, 2005;Shiri et al, 2004).…”